ImmunoPrecise Antibodies (NASDAQ:IPA) Introduces Transformative Ai-Driven Rapid Therapeutic Screening Platform
ImmunoPrecise Antibodies Ltd (NASDAQ:IPA) is an innovative company that is using the power of artificial intelligence in the realm of biotech. The company came into the news cycle yesterday that…